1.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
2.
Study of the Urokinase-type Plasminogen Activator Inhibited by Triplex-Forming Oligonucleotides in Rat Sertoli Cells;
三链形成寡核苷酸对大鼠Sertoli细胞尿激酶型纤溶酶原激活因子的反基因研究
3.
Study of the Roles and Mechanisms of Urokinase-type Plasminogen Activator in Promoting Male Fertility;
尿激酶型纤溶酶原激活因子多环节促雄性生育作用及相关机制探讨实验研究
4.
The invasion and metastasis of epithelial ovarian cancer be mediated by urokinase-type plasminogen activator in vitro
尿激酶型纤溶酶原激活因子介导的卵巢上皮癌细胞浸润转移体外的实验研究
5.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
6.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
7.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
8.
Treatment of Experimental Hepatic Fibrosis by Combination of Urokinase-type Plasminogen Activator and Hepatocyte Growth Factor Gene Delivery;
尿激酶型纤溶酶原激活剂和肝细胞生长因子联合基因治疗实验性肝纤维化
9.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响
10.
Expression and Prognostic Significance of Nuclear Factor-kappaBp-65 and uPA in Cervical Carcinoma;
核转录因子-kBp65和尿激酶型纤溶酶原激活剂在人宫颈癌中的表达及预后意义
11.
Expression and Regulation of Urokinase-type Plasminogen Activator in Supraglottic Laryngeal Cancer;
尿激酶型纤溶酶原激活剂在声门上型喉癌中的表达及调节机制
12.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
13.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
14.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
15.
Study on the Transcriptional Regulation of Urokinase Plasminogen Activator in Human Lung Cancer;
尿激酶型纤溶酶原激活物在人肺癌细胞中表达调控的研究
16.
The Experiment Research That the uPA to Suffer from the Relativity with the Arthritis Disease;
尿激酶型纤溶酶原激活物（uPA）与关节炎性疾患相关性的实验研究
17.
Expressions of Survivin and uPA in human cerebral gliomas
脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达
18.
Clinical significance of the expression of urokinase type plasminogen activator system in endometrial carcinoma
子宫内膜腺癌组织中尿激酶型纤溶酶原激活系统的表达及其临床意义